Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea · Delayed Price · Currency is KRW
16,350
-1,530 (-8.56%)
At close: Dec 5, 2025
KOSDAQ:014950 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
|---|
| 3,522 | 2,969 |
Depreciation & Amortization | 1,351 | 1,278 |
Loss (Gain) From Sale of Assets | -9.5 | -0.07 |
Asset Writedown & Restructuring Costs | 23.8 | - |
Loss (Gain) From Sale of Investments | -300.14 | -298.32 |
| 263.58 | 72.69 |
Provision & Write-off of Bad Debts | -2.68 | -65.12 |
Other Operating Activities | 1,391 | 696.68 |
Change in Accounts Receivable | 558.63 | -1,117 |
| -2,105 | -55.64 |
Change in Accounts Payable | 251.69 | -827.43 |
| - | -3.98 |
Change in Other Net Operating Assets | -559.9 | -400.44 |
| 4,385 | 2,248 |
Operating Cash Flow Growth | 95.04% | - |
| -842.32 | -1,374 |
Sale (Purchase) of Intangibles | -5.83 | -3.14 |
| -1,613 | -120.5 |
Other Investing Activities | - | -70 |
| -2,161 | -1,868 |
| -137.56 | -109.02 |
| -137.56 | -109.02 |
| 672.3 | - |
| -281 | -140.5 |
Other Financing Activities | -1.02 | - |
| 252.72 | -249.52 |
Miscellaneous Cash Flow Adjustments | - | -0 |
| 2,477 | 130.88 |
| 3,543 | 874.05 |
| 305.32% | - |
| 6.34% | 1.71% |
| 503.91 | 124.52 |
| 12.04 | 18.36 |
| 205.69 | 3.03 |
| 3,382 | - |
| 3,389 | - |
Change in Working Capital | -1,854 | -2,405 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.